Closing the data loop in AI-driven drug discovery

Drug discovery is a highcost, highrisk endeavor that is under growing pressure from a market increasingly defined by firstmover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law.